A systematic review compares survival outcomes in pediatric neuroblastoma, suggesting PBT may reduce long-term toxicity.
PBT gave survival outcomes that were at least comparable to XRT in pediatric neuroblastoma. Given its potential to reduce long-term toxicity, PBT may be a reasonable alternative in selected cases. Further prospective studies are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Nitta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: